Is EEOIF or MRK a better dividend investment in 2026?

EEOIF currently yields 2754.29% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: EEOIF offers higher current income.

What is the dividend yield difference between EEOIF and MRK?

EEOIF has a forward dividend yield of 2754.29% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 2751.53 percentage points.

Home › Compare › EEOIF vs MRK

EEOIF vs MRK: Dividend Comparison 2026

EEOIF yields 2754.29% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EEOIF wins by $201688685580.49M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EEOIF

● Live price

2754.29%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$201688685580.55M

Annual income

$188,244,039,455,792,320.00

Full EEOIF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — EEOIF vs MRK

📍 EEOIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EEOIF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EEOIF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EEOIF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EEOIF

Annual income on $10K today (after 15% tax)

$234,114.63/yr

After 10yr DRIP, annual income (after tax)

$160,007,433,537,423,460.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, EEOIF beats the other by $160,007,433,537,415,140.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EEOIF + MRK for your $10,000?

EEOIF: 50%MRK: 50%

100% MRK50/50100% EEOIF

Portfolio after 10yr

$100844342790.30M

Annual income

$94,122,019,727,901,060.00/yr

Blended yield

93.33%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EEOIF

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EEOIF buys

MRK buys

No recent congressional trades found for EEOIF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEEOIFMRK

Forward yield	2754.29% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$201688685580.55M ✓	$56.8K
Annual income after 10y	$188,244,039,455,792,320.00 ✓	$9,798.13
Total dividends collected	$200754718573.95M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EEOIF vs MRK ($10,000, DRIP)

Year	EEOIF Portfolio	EEOIF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$286,129	$275,428.98	$11,206	$366.19	+$274.9K → EEOIF
2	$7,671,412	$7,365,253.60	$12,650	$502.35	+$7.66M → EEOIF
3	$192,759,819	$184,551,408.70	$14,407	$694.19	+$192.75M → EEOIF
4	$4,540,112,348	$4,333,859,341.12	$16,585	$967.82	+$4540.10M → EEOIF
5	$100,256,327,465	$95,398,407,252.65	$19,342	$1,363.89	+$100256.31M → EEOIF
6	$2,076,078,519,926	$1,968,804,249,539.18	$22,913	$1,947.19	+$2076078.50M → EEOIF
7	$40,323,664,676,396	$38,102,260,660,075.37	$27,662	$2,823.89	+$40323664.65M → EEOIF
8	$734,791,231,801,334	$691,644,910,597,589.90	$34,159	$4,173.35	+$734791231.77M → EEOIF
9	$12,565,089,836,220,498	$11,778,863,218,193,072.00	$43,337	$6,308.80	+$12565089836.18M → EEOIF
10	$201,688,685,580,548,220	$188,244,039,455,792,320.00	$56,776	$9,798.13	+$201688685580.49M → EEOIF

EEOIF vs MRK: Complete Analysis 2026

EEOIF — Stock

Elegance Optical International Holdings Limited, an investment holding company, manufactures and trades in optical frames and sunglasses in Europe, the United States, the People's Republic of China, other Asian countries, and internationally. The company operates through Manufacturing and Trading, Property Investment, Debts and Securities Investment, Film Investment and Distribution, and Energy Business segments. It is also involved in property leasing; investing in financial instruments and quoted shares; film right and movie investment and distribution activities; investing in energy sector related instrument; selling and trading liquefied petroleum gas products; money lending activities; and trading of bags. The company was formerly known as Elegance International Holdings Limited and changed its name to Elegance Optical International Holdings Limited in September 2013. Elegance Optical International Holdings Limited is headquartered in Wan Chai, Hong Kong.

Full EEOIF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this EEOIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EEOIF vs SCHD EEOIF vs JEPI EEOIF vs O EEOIF vs KO EEOIF vs MAIN EEOIF vs JNJ EEOIF vs ABBV EEOIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.